Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid URU Metals Ltd. (DI) (URU) by Nigel Somerville in ShareProphets
- Sell Videndum (VID) by Steve Moore in ShareProphets
- Avoid PZ Cussons (PZC) by Steve Moore in ShareProphets
- Avoid TT Electronics (TTG) by Steve Moore in ShareProphets
- Sell Microsaic Systems (MSYS) by Steve Moore in ShareProphets
- Sell The Revel Collective (TRC) by Steve Moore in ShareProphets
- Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Avoid Naked Wines (WINE) by Steve Moore in ShareProphets
- Sell Mirriad Advertising (MIRI) by Steve Moore in ShareProphets
- Hold M&G (MNG) by Cliff D'Arcy in The Motley Fool
- Buy Safestore Holdings (SAFE) by Zaven Boyrazian in The Motley Fool
- Buy Altona Rare Earths (REE) by Hot Stock Rockets in ShareProphets
- Avoid Surgical Innovations Group (SUN) by Steve Moore in ShareProphets
- Outperform OSB Group (OSB) by RBC Capital
- Buy Diageo (DGE) by Harvey Jones in The Motley Fool
- Watch Nexteq (NXQ) by Steve Moore in ShareProphets
- Overweight Jet2 (JET2) by Barclays
- Outperform IntegraFin Holding (IHP) by RBC Capital
- Outperform Volution Group (FAN) by RBC Capital
- Sector Perform Currys (CURY) by RBC Capital
Maxcyte (DI) (MXCT) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Maxcyte (DI) (MXCT)
| Latest Bid : 150.00p | Latest Ask : 153.00p |
| High Today : 160.00p | Low Today : 148.00p |
| This Years High : 405.00p | This Years Low : 148.00p |
| Volume : 100,435 | MKT Cap : £159.6M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Maxcyte (DI) (MXCT) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.Maxcyte (DI) (MXCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | -37.96% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -57.78% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -54.05% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |
Maxcyte (DI) (MXCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 150.00p | Latest Ask : 153.00p |
| High Today : 160.00p | Low Today : 148.00p |
| This Years High : 405.00p | This Years Low : 148.00p |
| Volume : 100,435 | MKT Cap : £159.6M |
Maxcyte (DI) Overview
We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners' challenges by applying our expertise.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Maxcyte (DI) Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Hold | Robert Stephens (Telegraph) | Premium Only | 2023-10-11 06:00:00 11/10/2023 | -37.96% |
| Buy | Numis | Premium Only | 2023-03-16 18:00:00 16/03/2023 | -57.78% |
| Hold | Robert Stephens (Telegraph) | Premium Only | 2022-04-20 07:45:00 20/04/2022 | -54.05% |
| Buy | Sabah Meddings | Premium Only | 2021-10-10 08:45:00 10/10/2021 | -61.96% |
| Hold | Richard Evans | Premium Only | 2021-08-11 07:50:00 11/08/2021 | -70.00% |